Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a major cause of death and disability. TBI results in a prolonged secondary central neuro-inflammatory response. Previously, we have demonstrated that multiple doses (2 and 24 h after TBI) of multipotent adult progenitor cells (MAPC) delivered intravenousl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neuroinflammation
Principais autores: Bedi, Supinder S., Aertker, Benjamin M., Liao, George P., Caplan, Henry W., Bhattarai, Deepa, Mandy, Fanni, Mandy, Franciska, Fernandez, Luis G., Zelnick, Pamela, Mitchell, Matthew B., Schiffer, Walter, Johnson, Margaret, Denson, Emma, Prabhakara, Karthik, Xue, Hasen, Smith, Philippa, Uray, Karen, Olson, Scott D., Mays, Robert W., Cox, Charles S.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5856201/
https://ncbi.nlm.nih.gov/pubmed/29548333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-018-1122-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados